Ep105: Nello Mainolfi on Targeted Protein Degraders episode artwork

EPISODE · Dec 6, 2021 · 1H 8M

Ep105: Nello Mainolfi on Targeted Protein Degraders

from The Long Run with Luke Timmerman · host Timmerman Report

Nello Mainolfi, CEO of Kymera Therapeutics, on targeted protein degrading small molecule drugs.

Nello Mainolfi, CEO of Kymera Therapeutics, on targeted protein degrading small molecule drugs.

NOW PLAYING

Ep105: Nello Mainolfi on Targeted Protein Degraders

0:00 1:08:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 8 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on December 6, 2021.

What is this episode about?

Nello Mainolfi, CEO of Kymera Therapeutics, on targeted protein degrading small molecule drugs.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!